Skip to main content
Premium Trial:

Request an Annual Quote

Synthesis Security Sought

Lawmakers in California are considering a bill that would require gene synthesis companies to adopt security protocols to prevent people with nefarious intent from obtaining dangerous stretches of DNA, Stat News reports.

As Stat News notes, scientists routinely order genes from manufacturers that synthesize them at scale for use in a range of studies. But as NPR reported in 2019, there are also concerns that people could use synthetic genes to piece together pathogens or develop bioweapons.

Rudy Salas, a Democratic California Assembly member who introduced the new bill, tells Stat News he was concerned to learn there was limited oversight of the field. The new bill would require gene synthesis companies in California to join the International Gene Synthesis Consortium, a trade group, and follow its criteria for which genes can be synthesized and to whom they can be sold, it adds.

"It's hard to argue against it," Emily Leproust, CEO of Twist Bioscience, which is an IGSC member, tells Stat News. She adds that it is "work to catch the extreme edge cases, but it's worth the effort because the downside is pretty high."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.